Company Filing History:
Years Active: 2018
Title: Huixing Liang: Innovator in Pharmaceutical Development
Introduction
Huixing Liang is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on yonkenafil hydrochloride.
Latest Patents
Huixing Liang holds a patent for a polymorphic substance of yonkenafil hydrochloride, along with its preparation method, composition, and use. The patent details an A-type polymorphic substance characterized by a specific powder diffraction pattern. This pattern includes diffraction peaks at various 2θ values, such as 8.4±0.2°, 11.3±0.2°, and 14.2±0.2°, among others. This invention is crucial for enhancing the efficacy and application of yonkenafil hydrochloride in medical treatments.
Career Highlights
Liang is associated with the Yangtze River Pharmaceutical Group Co., Ltd., where he has been instrumental in advancing pharmaceutical research and development. His work has not only contributed to the company's portfolio but has also impacted the broader pharmaceutical industry.
Collaborations
He has collaborated with notable colleagues, including Haibo Zhang and Lingwu Chen, to further enhance the research and development efforts within his organization.
Conclusion
Huixing Liang's innovative contributions to the pharmaceutical field, particularly through his patent on yonkenafil hydrochloride, highlight his role as a key inventor in advancing medical science. His work continues to influence the development of effective pharmaceutical solutions.